Actavis Reveals Allergan Breakup Fee, Board Picks
Actavis PLC on Tuesday offered more details on the biggest deal-making play of the year, its planned $66 billion tie-up with Allergan PLC, including a multibillion-dollar termination fee and board representation...To view the full article, register now.
Already a subscriber? Click here to view full article